NASDAQ:PPH VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News → Are you prepared for a Chinese 'invasion?' (From Behind the Markets) (Ad) Free PPH Stock Alerts $91.62 -0.06 (-0.07%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$91.24▼$91.6850-Day Range$84.87▼$92.6652-Week Range$74.05▼$92.97Volume150,698 shsAverage Volume140,796 shsMarket Capitalization$544.22 millionAssets Under Management$585.38 millionDividend Yield1.70%Net Expense Ratio0.36% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Pharmaceutical ETF alerts: Email Address About VanEck Pharmaceutical ETF (NASDAQ:PPH)The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.Read More PPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PPH ETF News HeadlinesJune 17 at 1:38 PM | americanbankingnews.comShort Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Expands By 22.4%June 16 at 3:10 AM | americanbankingnews.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading VolumeMay 8, 2024 | msn.comJust Say No to Drugs: 3 Pharma Stocks to AvoidApril 23, 2024 | seekingalpha.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 18, 2024 | theglobeandmail.comCanada’s updated guidance on ESG-related investment fund disclosureApril 3, 2024 | msn.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328April 1, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328March 7, 2024 | investorplace.comThe Top 3 ETFs to Buy in March 2024See More Headlines Receive PPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Pharmaceutical ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:PPH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$585.38 million Average Daily Volume$142,951.50 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerIMC Options OptionableOptionable Options Volume35 Put Options6 Call Options29 Short Interest1,420,000 shs Miscellaneous Outstanding Shares5,940,000Beta0.72 Creation Unit50,000 Creation Fee$500.00 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> VanEck Pharmaceutical ETF ExpensesTypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.47%0.51%Other Expenses0.01%0.33%0.50%0.39%0.54%Total Expense0.36%0.70%0.70%0.60%0.71%Fee Waiver0.00%-0.45%-0.55%-0.32%-0.60%Net Expense0.36%0.61%0.60%0.54%0.58% VanEck Pharmaceutical ETF (PPH) Holdings & ExposureTop 10 PPH HoldingsEli Lilly and Company(NYSE:LLY)Holding Weight: 12.47%Novo Nordisk A/S(NYSE:NVO)Holding Weight: 10.30%Johnson & Johnson(NYSE:JNJ)Holding Weight: 6.08%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 6.07%AstraZeneca(NASDAQ:AZN)Holding Weight: 6.04%AbbVie(NYSE:ABBV)Holding Weight: 5.53%Novartis AG ADRHolding Weight: 5.09%McKesson(NYSE:MCK)Holding Weight: 4.90%Pfizer(NYSE:PFE)Holding Weight: 4.65%Sanofi(NASDAQ:SNY)Holding Weight: 4.56%PPH Sector ExposurePPH Industry ExposureFull Holdings Details Similar ETFsVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipCetera Investment AdvisersBought 19,912 shares on 5/24/2024Ownership: 0.441%Cetera Advisors LLCBought 6,682 shares on 5/24/2024Ownership: 0.112%Comerica BankBought 378 shares on 5/17/2024Ownership: 0.023%Beck Capital Management LLCBought 897 shares on 5/15/2024Ownership: 0.353%Axxcess Wealth Management LLCSold 1,394 shares on 5/14/2024Ownership: 0.172%View All Institutional Transactions PPH ETF - Frequently Asked Questions How have PPH shares performed in 2024? VanEck Pharmaceutical ETF's stock was trading at $81.37 at the beginning of the year. Since then, PPH stock has increased by 12.6% and is now trading at $91.62. View the best growth stocks for 2024 here. Are investors shorting VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 1,420,000 shares, an increase of 22.4% from the May 15th total of 1,160,000 shares. Based on an average trading volume of 149,400 shares, the short-interest ratio is currently 9.5 days. View VanEck Pharmaceutical ETF's Short Interest. How often does VanEck Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF announced a dividend on Thursday, March 28th. Stockholders of record on Tuesday, April 2nd will be paid a dividend of $0.5328 per share on Friday, April 5th. The ex-dividend date is Monday, April 1st. Read our dividend analysis for PPH. What does PPH invest in? VanEck Pharmaceutical ETF is a equity fund issued by Van Eck. PPH focuses on health care investments and follows the Market Vectors US Listed Pharmaceutical 25 Index. The fund's investments total to approximately $585.38 million assets under management. What stocks does VanEck Pharmaceutical ETF hold? PPH invests in 26 holdings. Some of the stocks in their portfolio include Eli Lilly and Company (LLY), Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AstraZeneca (AZN), AbbVie (ABBV), McKesson (MCK), Pfizer (PFE), Sanofi (SNY) and Haleon (HLN). What is the management fee for VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF's management fee is 0.35% and has other expenses of 0.01%. The net expense ratio for PPH is 0.36%. What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO? 38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of VanEck Pharmaceutical ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK), Applied Materials (AMAT), Applied Graphene Materials (AGM), Air Canada (AC) and Abbott Laboratories (ABT). Who are VanEck Pharmaceutical ETF's major shareholders? VanEck Pharmaceutical ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Avalon Trust Co (4.80%), J.Safra Asset Management Corp (1.17%), Orion Portfolio Solutions LLC (0.56%), Kingsview Wealth Management LLC (0.51%), Cetera Investment Advisers (0.44%) and Commonwealth Equity Services LLC (0.37%). How do I buy shares of VanEck Pharmaceutical ETF? Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PPH) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.